+49 711 500 989 80
deen

Widely-used hormone drug associated with increased risk of benign brain tumor at high doses



Widely-used hormone drug associated with increased risk of benign brain tumor at high doses

High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma — the most common type of benign brain tumor, finds a new study of over 8-million patients.

Materials provided by University of Bristol. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th May 2022

High cost of cancer care in the U.S. doesn't reduce mortality rates

Read more
27th May 2022

T cell warriors need their R & R

Read more
27th May 2022

New cancer subtype may illuminate treatment strategy

Read more